• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed-mutation rate of the marker higher than expected.

Kappel-Latif, Sonja, Zacherl, Johannes, Hejna, Michael, Westerhoff, Maria, Tamandl, Dietmar, Ba-Ssalamah, Ahmed, Mittlböck, Martina, Wolf, Brigitte, Wrba, Friedrich, Kührer, Irene, Pluschnig, Ursula, Schoppmann, Sebastian F, Függer, Reinhold, Zwrtek, Ronald, Glaser, Karl, Karner, Josef, Längle, Friedrich, Wenzl, Etienne, Roka, Rudolf, Öfner, Dietmar, Tschmelitsch, Jörg, Hold, Michael, Keil, Felix, Gnant, Michael and Kandioler, Daniela (2018) • Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed-mutation rate of the marker higher than expected. European surgery : ACA : Acta chirurgica Austriaca, 50 (4). pp. 160-166. ISSN 1682-8631

Full text not available from this repository.

Item Type:	Fachpublikation (peer reviewed)
Divisions:	Ordensklinikum Linz Barmherzige Schwestern > Allgemeinchirurgie mit Viszeralchirurgie
Depositing User:	Prof. Reinhold Fuegger
Date Deposited:	17 Apr 2019 06:54
Last Modified:	17 Feb 2025 09:33
URI:	https://eprints.vinzenzgruppe.at/id/eprint/8708

Edit Item